Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (2295)	2/26/2008 3:26:40 PM
From: Jibacoa	Read Replies (1) \| Respond to of 3722

PTN is up 22.23% in spite of its significantly lower revenues on the 2ndQ, but it was able to trim its loss in half & the stock has now doubled since its Dec 22 L at $0.19 <g> bigcharts.marketwatch.com Bernard

To: Jibacoa who wrote (2295)	4/14/2008 11:52:58 PM
From: Jibacoa	Respond to of 3722

NRMX was up 12.99% on volume of 170,380 which was > its ADV. The stock closed at its intraday H as it was able to reach the $2 level, which it had been unable to do since Jan 18.<g> bigcharts.marketwatch.com NRMX has scheduled its Annual & Special Meeting of shareholders for tomorrow. As previously mentioned, the stock has a good amount of resistance above the $2 level, but with some good news it could double from present levels. The short ratio is around 25x its ADV.<g> bigcharts.marketwatch.com Bernard